Trade

with

ImmuCell Corp
(NASDAQ: ICCC)
AdChoices
=
4.59
0.00
0.00%
After Hours :
-
-
-

Open

4.58

Previous Close

4.59

Volume (Avg)

2.27k (4.39k)

Day's Range

4.58-4.59

52Wk Range

3.30-5.68

Market Cap.

13.89M

Dividend Rate ( Yield )

-

Beta

-0.42

Shares Outstanding

3.03M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 6.01M

    • Net Income

    • 117.40k

    • Market Cap.

    • 13.89M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -6.26

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -0.42

    • Forward P/E

    • -

    • Price/Sales

    • 2.19

    • Price/Book Value

    • 1.53

    • Price/Cash flow

    • 30.21

      • EBITDA

      • 689.15k

      • Return on Capital %

      • -3.63

      • Return on Equity %

      • -4.33

      • Return on Assets %

      • -3.63

      • Book Value/Share

      • 3.01

      • Shares Outstanding

      • 3.03M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 12.70

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • 31.20

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 5.33

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 50.69

            • 82.75

            • Pre-Tax Margin

            • -10.12

            • 39.38

            • Net Profit Margin

            • -6.26

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 53.70

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -6.30

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -3.60

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.09

              • 0.76

              • Current Ratio

              • 7.64

              • 2.92

              • Quick Ratio

              • 6.19

              • 2.35

              • Interest Coverage

              • -18.75

              • 38.02

              • Leverage Ratio

              • 1.18

              • 2.21

              • Book Value/Share

              • 3.01

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -36.63

                • 243.90

                • P/E Ratio 5-Year High

                • -64.01

                • 634.30

                • P/E Ratio 5-Year Low

                • -18.60

                • 124.82

                • Price/Sales Ratio

                • 2.32

                • 9.29

                • Price/Book Value

                • 1.62

                • 8.39

                • Price/Cash Flow Ratio

                • 30.21

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -4.33

                        (-1.70)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -3.63

                        (-1.50)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -3.68

                        (-1.90)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 2.51

                      • 1.48

                      • Asset Turnover

                      • 0.58

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -19.55k
                      Operating Margin
                      -0.33
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      30.21
                      Ownership

                      Institutional Ownership

                      8.81%

                      Top 10 Institutions

                      8.73%

                      Mutual Fund Ownership

                      2.93%

                      Float

                      72.30%

                      5% / Insider Ownership

                      29.98%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • HealthInvest MicroCap Fund

                      •  

                        78,477

                      • -3.05

                      • 2.59

                      • Vanguard Total Stock Mkt Idx

                      •  

                        5,733

                      • 0.00

                      • 0.19

                      • Vanguard US Equity Index

                      •  

                        4,242

                      • 0.00

                      • 0.14

                      • Marketocracy Masters 100 Fund

                      •  

                        400

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • HealthInvest Partners AB

                      •  

                        105,350

                      • +34.24%

                      • 3.48

                      • Shufro Rose & CO LLC

                      •  

                        52,968

                      • 0.00%

                      • 1.75

                      • GRT Capital Partners LLC

                      •  

                        34,467

                      • +13.13%

                      • 1.14

                      • Essex Financial Services, Inc.

                      •  

                        23,776

                      • 0.00%

                      • 0.79

                      • Morgan Stanley Smith Barney LLC

                      •  

                        17,611

                      • -33.12%

                      • 0.58

                      • Renaissance Technologies Corp

                      •  

                        15,500

                      • +13.14%

                      • 0.51

                      • Vanguard Group Inc.

                      •  

                        9,975

                      • 0.00%

                      • 0.33

                      • Wells Fargo Advisors, LLC

                      •  

                        2,001

                      • +200,000.00%

                      • 0.07

                      • Columbia Management Company

                      •  

                        1,532

                      • 0.00%

                      • 0.05

                      • UBS Financial Services Inc.

                      •  

                        1,000

                      • 0.00%

                      • 0.03

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      Small Core

                      ImmuCell Corp is engaged in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries.

                      Key People

                      Micheal F. Brigham

                      CEO/President/Director/Treasurer/Secretary/CFO

                      Dr. David S. Tomsche

                      Director/Chairman of the Board

                      Joseph H. Crabb,PhD

                      Chief Scientific Officer/Director/Vice President

                      Jonathan F. Rothschild

                      Director

                      Dr. Linda Rhodes,PhD

                      Director

                      • ImmuCell Corp

                      • 56 Evergreen Drive

                      • Portland, ME 04103

                      • USA.Map

                      • Phone: +1 207 878-2770

                      • Fax: -

                      • immucell.com

                      Incorporated

                      1982

                      Employees

                      34

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: